| |
| | Patent 6,582,737 |
 | | The present invention is directed to a pharmaceutical composition in unit dosage form combining two pharmaceutically active ingredients to alleviate tobacco-smoking withdrawal symptoms which comprises: |
 | | Such transdermal patches containing the azapirone may be found for example in U.S. Pat. |
 | | The azapirone is preferably buspirone, but may also include gepirone, ipsapirone, tandospirone, WY-47,846, MDL-73005 EF or BP-554. |
| www.pharmcast.com /Patents/Yr2003/Jun2003/062403/6582737_Smoking062403.htm (1753 words) |
|